EssilorLuxottica stock (FR0000121667): Global leader in eyewear with strong US market presence
13.05.2026 - 15:35:16 | ad-hoc-news.deEssilorLuxottica maintains its position as a key player in the global eyewear industry, combining advanced lens technology with iconic frame brands. The company, formed by the 2018 merger of Essilor and Luxottica, operates in over 150 countries and holds significant exposure to the US market, where vision care demand remains robust amid aging demographics and digital eye strain trends.
As of: 13.05.2026
By the editorial team – specialized in equity coverage.
At a glance
- Name: EssilorLuxottica
- Sector/industry: Healthcare / Eyewear and Vision Care
- Headquarters/country: France / Italy
- Core markets: North America, Europe, Asia-Pacific
- Key revenue drivers: Prescription lenses, sunglasses, ophthalmic equipment
- Home exchange/listing venue: Euronext Paris (EL.PA)
- Trading currency: EUR
Official source
For first-hand information on EssilorLuxottica, visit the company’s official website.
Go to the official websiteEssilorLuxottica: core business model
EssilorLuxottica integrates the full eyewear value chain, from lens manufacturing to retail distribution. Its dual structure spans Essilor's expertise in corrective lenses and Luxottica's dominance in branded frames and optical retail. This vertical integration allows control over quality, pricing, and supply chain efficiency, serving opticians, wholesalers, and over 18,000 stores worldwide, including major US chains like LensCrafters and Sunglass Hut.
The company's portfolio features premium brands such as Ray-Ban, Oakley, and Vogue Eyewear, alongside professional lens solutions like Varilux progressives and Crizal coatings. EssilorLuxottica also invests in digital tools, including virtual try-on apps and AI-driven prescription services, adapting to e-commerce growth in vision care.
Main revenue and product drivers for EssilorLuxottica
Revenue primarily derives from lenses (about 45%), frames and sunglasses (35%), and equipment/services (20%), based on the full-year 2024 report published March 2025. North America contributes roughly 40% of sales, fueled by US consumer spending on premium eyewear and Medicare-covered vision benefits. Key drivers include Transitions photochromic lenses and Stellest myopia-control lenses for children, addressing rising nearsightedness rates.
Sunglass segment growth is propelled by sports and lifestyle brands like Oakley, popular among US athletes and outdoor enthusiasts. Strategic partnerships, such as with Meta for smart glasses, position EssilorLuxottica in emerging connected eyewear markets relevant to US tech consumers.
Industry trends and competitive position
The global eyewear market, valued at over $140 billion in 2024 per Statista data published January 2025, grows at 5-7% annually, driven by aging populations and screen time. EssilorLuxottica commands about 20% market share in lenses and 15% in frames, outpacing rivals like Johnson & Johnson Vision and Safilo. Its scale enables R&D investment exceeding €1 billion yearly, focusing on sustainable materials and blue-light filtering tech amid US regulatory pushes for eye health.
Why EssilorLuxottica matters for US investors
With 40% of revenue from North America, EssilorLuxottica benefits directly from US healthcare spending and retail recovery. Brands like Ray-Ban hold strong cultural resonance in the US, while acquisitions like Supreme in 2024 enhance streetwear appeal to younger demographics. US listing accessibility via OTC (ESLOY) and ETF exposure provides retail investors entry to this defensive sector stock.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Conclusion
EssilorLuxottica stands as a resilient force in eyewear, leveraging brand strength and innovation for steady growth. Its US market footprint underscores relevance for American portfolios seeking healthcare stability. Investors track upcoming earnings and product launches for insights into sustained performance amid evolving vision care demands.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis EssilorLuxottica Aktien ein!
Für. Immer. Kostenlos.
